Figures computed from official regulatory filings — .
Analysttarget 8 USD (+2005%) · consensus 4/5 · 1 buy · 0 hold · 0 sell
Ownershipinsiders 13.51% · institutions 3.97% · short 2.8% of float
In USD · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for AVENUE THERAPEUTICS, INC. only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Avenue Therapeutics, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of neurologic diseases. The company product candidates include ATX-04, a small molecule therapy for the treatment of Pompe disease; and intravenous tramadol, a schedule IV opioid to treat post-operative acute pain. The company was incorporated in 2015 and is headquartered in Bay Harbor Islands, Florida.
Market information source · Oct 5, 2026
SEC company identity · Oct 5, 2026
Open-market timeline · full history
40 buys13 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
| CORONADO BIOSCIENCES INC | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| CORONADO BIOSCIENCES INC | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Herskowitz Neiltrack record | Sell | $46 | SEC |
| KRANZLER JAY D | Sell | $136.6 | SEC |
| KRANZLER JAY D | Buy | $1.2K | conv 73 | SEC |
| KRANZLER JAY D | Buy | $7.2 | conv 51First in 12mo | SEC |
| KRANZLER JAY D | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Herskowitz Neiltrack record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Oltmans Curtis Gale | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Jin David | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| MacLean Alexandra | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Charles Faith L. | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| ROSENWALD LINDSAY A MDtrack record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| CORONADO BIOSCIENCES INC | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| CORONADO BIOSCIENCES INC | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Davidow Robert L | Sell | $8.5K | SEC |
| Davidow Robert L | Sell | $17.6K | SEC |
| Davidow Robert L | Sell | $17.9K | SEC |
| Davidow Robert L | Sell | $37K | SEC |
| Davidow Robert L | Sell | $2.7K | SEC |
| Davidow Robert L | Sell | $2.8K | SEC |
| CORONADO BIOSCIENCES INC | Buy | $301.3K | conv 71First in 12mo | SEC |
| ROSENWALD LINDSAY A MDtrack record | Buy | $251K | conv 56 | SEC |
| Herskowitz Neiltrack record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| ROSENWALD LINDSAY A MDtrack record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |